FDA Inspection
Graviti Pharmaceuticals Private LimitedGraviti Pharmaceuticals Private Limited – FDA Inspection, Jul 28, 2026
Record Details
This FDA Inspection record concerns Graviti Pharmaceuticals Private Limited, with an inspection on July 28, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · cd7314df-6823-4dec-8ec5-868f44c01082
Inspection Facts
- Inspection number
- 1329590
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.84(d)(2)Component written specification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Graviti Pharmaceuticals Private Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 3, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 13, 2018 | Not classified | Office of Inspections and Investigations | |
| August 4, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Graviti Pharmaceuticals Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.